A new study suggests that 40% of American adults have conditions that could benefit from semaglutide treatment.
In 2023, Canada’s federal, provincial, and territorial ministers of health and agriculture released a Pan-Canadian Action ...
A survey of primary investigators on a PET/CT imaging study showed agreement on returning clinically actionable findings to ...